Basic Information
LncRNA/CircRNA Name | lncARSR |
Synonyms | NA |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot etc |
Sample | NSCLC and matched non-tumor samples,cell lines (16HBE,SPC-A1, A549, H23 and H1299) |
Expression Pattern | up-regulated |
Function Description | Moreover, ectopic expression of lncARSR suppressed PTEN expression and induced Akt phosphorylation in A549 cells. The expression level of PTEN was higher in NSCLC samples than in adjacent non-tumor specimens. PTEN expression was negatively correlated with lncARSR in NSCLC specimens. Furthermore, we demonstrated that overexpression of lncARSR induced NSCLC cell growth and migration via regulating the PTEN/Akt signaling pathway. These results suggest that lncARSR acts as an oncogene in NSCLC development and could serve as a new potential therapeutic target. |
Pubmed ID | 32269718 |
Year | 2020 |
Title | LncARSR Promotes Non-Small-Cell Lung Cancer Progression via Regulating PTEN/Akt |
External Links
Links for lncARSR | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |